Siregar, G., Paramesh, R., Kumawat, R., D, P. and HA, S. 2021. A prospective, interventional clinical study to evaluate the safety and efficacy of Liv.52 DS in the management of non-alcoholic fatty liver disease. European Journal of Clinical and Experimental Medicine. 19, 2 (Jun. 2021), 129–136. DOI:https://doi.org/10.15584/ejcem.2021.2.3.